CoChat

Mechanisms for suppressing NADPH oxidase in the vascular wall

Open access
Dusting, Gregory J, Selemidis, Stavros, Jiang, Fan · 2005 · Memórias do Instituto Oswaldo Cruz
Cited by 62

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Oxidative stress underlies many forms of vascular disease as well as tissue injury following ischemia and reperfusion. The major source of oxidative stress in the artery wall is an NADPH oxidase. This enzyme complex as expressed in vascular cells differs from that in phagocytic leucocytes both in biochemical structure and functions. The crucial flavin-containing catalytic subunits, Nox1 and Nox4, are not found in leucocytes, but are highly expressed in vascular cells and upregulated with vascular remodeling, such as that found in hypertension and atherosclerosis. The difference in catalytic subunits offers the opportunity to develop "vascular specific" NADPH oxidase inhibitors that do not compromise the essential physiological signaling and phagocytic functions carried out by reactive oxygen and nitrogen species. Nitric oxide and targeted inhibitors of NADPH oxidase that block the source of oxidative stress in the vasculature are more likely to prevent the deterioration of vascular function that leads to stroke and heart attack, than are conventional antioxidants. The roles of Nox isoforms in other inflammatory conditions are yet to be explored.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1590/s0074-02762005000900016

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 44

  1. Al-Mehdi AB, 1998, Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+, Circ Res, 83, 730, 10.1161/01.RES.83.7.730 · DOI · Paper page
  2. Babior BM, 1999, NADPH oxidase: an update, Blood, 93, 1464, 10.1182/blood.V93.5.1464 · DOI · Paper page
  3. Barry-Lane PA, 2001, p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice, J Clin Invest, 108, 1513, 10.1172/JCI200111927 · DOI · Paper page
  4. Baykal Y, 2003, Effects of antihypertensive agents, alpha receptor blockers, beta blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and calcium channel blockers, on oxidative stress, J Hypertens, 21, 1207, 10.1097/00004872-200306000-00022 · DOI
  5. Beckman JS, 1990, Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide, Proc Natl Acad Sci USA, 87, 1620, 10.1073/pnas.87.4.1620 · DOI · Paper page
  6. Bengtsson SH, 2003, Novel isoforms of NADPH oxidase in vascular physiology and pathophysiology, Clin Exp Pharmacol Physiol, 30, 849, 10.1046/j.1440-1681.2003.03929.x · DOI · Paper page
  7. Boota A, 2000, Prenyltransferase inhibitors block superoxide production by pulmonary vascular smooth muscle, Am J Physiol Lung Cell Mol Physiol, 278, L329, 10.1152/ajplung.2000.278.2.L329 · DOI
  8. Cayatte AJ, 2001, S17834, a new inhibitor of cell adhesion and atherosclerosis that targets nadph oxidase, Arterioscler Thromb Vasc Biol, 21, 1577, 10.1161/hq1001.096723 · DOI · Paper page
  9. Chen Z, 2004, Decreased neointimal formation in Nox2-deficient mice reveals a direct role for NADPH oxidase in the response to arterial injury, Proc Natl Acad Sci USA, 101, 13014, 10.1073/pnas.0405389101 · DOI · Paper page
  10. Cheng G, 2001, Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5, Gene, 269, 131, 10.1016/S0378-1119(01)00449-8 · DOI · Paper page
  11. Dodd OJ, 2000, Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion lung injury, Am J Physiol Heart Circ Physiol, 279, H303, 10.1152/ajpheart.2000.279.1.H303 · DOI · Paper page
  12. Drummond GR, 2003, Importance of the Nox4 subunit in NADPH oxidase-derived superoxide production in vascular smooth muscle cells, Circulation, 108, IV
  13. Dusting GJ, 1999, Endothelial dysfunction associated with cardiovascular disease and transplantation, 410
  14. Dusting GJ, 1998, Nitric oxide in atherosclerosis: vascular protector or villain?, Clin Exp Pharmacol Physiol, 25, S34, 10.1111/j.1440-1681.1998.tb02298.x · DOI · Paper page
  15. Gorzalczany Y, 2000, Targeting of Rac1 to the phagocyte membrane is sufficient for the induction of NADPH oxidase assembly, J Biol Chem, 275, 40073, 10.1074/jbc.M006013200 · DOI · Paper page
  16. Griendling KK, 2000, NAD(P)H oxidase: role in cardiovascular biology and disease, Circ Res, 86, 494, 10.1161/01.RES.86.5.494 · DOI · Paper page
  17. Guzik TJ, 2000, Vascular superoxide production by NAD(P)H Oxidase: association with endothelial dysfunction and clinical risk factors, Circ Res, 86, E85, 10.1161/01.RES.86.9.e85 · DOI · Paper page
  18. Hwang J, 2003, Pulsatile versus oscillatory shear stress regulates NADPH oxidase subunit expression: implication for native LDL oxidation, Circ Res, 93, 1225, 10.1161/01.RES.0000104087.29395.66 · DOI · Paper page
  19. Jacobson GM, 2003, Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery, Circ Res, 92, 637, 10.1161/01.RES.0000063423.94645.8A · DOI · Paper page
  20. Jiang F, 2003, Natural phenolic compounds as cardiovascular therapeutics: potential role of their antiinflammatory effects, Curr Vasc Pharmacol, 1, 135, 10.2174/1570161033476736 · DOI
  21. Jiang F, 2002, Inhibition of ge-ranylgeranylation of small G protein Rac suppresses NADPH oxidase activity in rat aortic smooth muscle cells, Pharmacologist, 44, A90
  22. Kunsch C, 1999, Oxidative stress as a regulator of gene expression in the vasculature, Circ Res, 85, 753, 10.1161/01.RES.85.8.753 · DOI · Paper page
  23. Maack C, 2003, Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment, Circulation, 108, 1567, 10.1161/01.CIR.0000091084.46500.BB · DOI · Paper page
  24. Munzel T, 1999, Role for NADPH/NADH oxidase in the modulation of vascular tone, Ann NY Acad Sci, 874, 386, 10.1111/j.1749-6632.1999.tb09253.x · DOI · Paper page
  25. O'Donnell BV, 1993, Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase, Biochem J, 290, 41, 10.1042/bj2900041 · DOI · Paper page
  26. Paravicini TM, 2002, Increased NADPH oxidase activity, gp91phox expression, and endothelium- dependent vasorelaxation during neointima formation in rabbits, Circ Res, 91, 54, 10.1161/01.RES.0000024106.81401.95 · DOI · Paper page
  27. Rey FE, 2001, Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice, Circ Res, 89, 408, 10.1161/hh1701.096037 · DOI · Paper page
  28. Seshiah PN, 2002, Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators, Circ Res, 91, 406, 10.1161/01.RES.0000033523.08033.16 · DOI · Paper page
  29. Shi J, 1996, PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47 phox, Proc Natl Acad Sci USA, 93, 6014, 10.1073/pnas.93.12.6014 · DOI · Paper page
  30. Souza HP, 2000, Vascular oxidant stress early after balloon injury: evidence for increased NAD(P)H oxidoreductase activity, Free Radic Biol Med, 28, 1232, 10.1016/S0891-5849(00)00240-9 · DOI
  31. Steinberg D, 2002, Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime, Nat Med, 8, 1211, 10.1038/nm1102-1211 · DOI · Paper page
  32. Stolk J, 1994, Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol, Am J Respir Cell Mol Biol, 11, 95, 10.1165/ajrcmb.11.1.8018341 · DOI · Paper page
  33. Stuehr DJ, 1991, Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyl-eneiodonium and its analogs, Faseb J, 5, 98, 10.1096/fasebj.5.1.1703974 · DOI · Paper page
  34. Thum T, 2004, Mechanistic role of cytochrome P450 monooxygenases in oxidized low-density lipoprotein-induced vascular injury: therapy through LOX-1 receptor antagonism?, Circ Res, 94, e1, 10.1161/01.RES.0000110081.03480.E9 · DOI
  35. Touyz RM, 2003, c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells, Arterioscler Thromb Vasc Biol, 23, 981, 10.1161/01.ATV.0000069236.27911.68 · DOI · Paper page
  36. Ushio-Fukai M, 2002, Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis, Circ Res, 91, 1160, 10.1161/01.RES.0000046227.65158.F8 · DOI · Paper page
  37. Wagner AH, 2000, Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation, Arterioscler Thromb Vasc Biol, 20, 61, 10.1161/01.ATV.20.1.61 · DOI · Paper page
  38. Warnholtz A, 1999, Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system, Circulation, 99, 2027, 10.1161/01.CIR.99.15.2027 · DOI · Paper page
  39. Wattanapitayakul SK, 2001, Oxidative pathways in cardiovascular disease: roles, mechanisms, and therapeutic implications, Pharmacol Ther, 89, 187, 10.1016/S0163-7258(00)00114-5 · DOI · Paper page
  40. West N, 2001, Enhanced superoxide production in experimental venous bypass graft intimal hyperplasia: role of NAD(P)H oxidase, Arterioscler Thromb Vasc Biol, 21, 189, 10.1161/01.ATV.21.2.189 · DOI
  41. White CR, 1994, Superoxide and peroxynitrite in atherosclerosis, Proc Natl Acad Sci USA, 91, 1044, 10.1073/pnas.91.3.1044 · DOI · Paper page
  42. Yang S, 2001, A new superoxide-generating oxidase in murine osteoclasts, J Biol Chem, 276, 5452, 10.1074/jbc.M001004200 · DOI · Paper page
  43. Zalba G, 2000, Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats, Hypertension, 35, 1055, 10.1161/01.HYP.35.5.1055 · DOI · Paper page
  44. Zicha J, 2001, Relative deficiency of nitric oxide-dependent vasodilation in salt- hypertensive Dahl rats: the possible role of superoxide anions, J Hypertens, 19, 247, 10.1097/00004872-200102000-00011 · DOI

Cited by

See all 62

Metadata

Authors
Dusting, G. J., Selemidis, S., & Jiang, F.
Venue
Memórias do Instituto Oswaldo Cruz
Published
2005-03
Volume
100
Issue
suppl 1
Pages
97-103
ISSN
0074-0276 (ISSN-L)
OpenAlex
W2152467696
Cited by
62
References
9
FWCI
3.10
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanisms for suppressing NADPH oxidase in the vascular wall. https://app.cochat.ai/papers/10.1590/s0074-02762005000900016
The paper
Dusting, G. J., Selemidis, S., & Jiang, F. (2005). Mechanisms for suppressing NADPH oxidase in the vascular wall. Memórias do Instituto Oswaldo Cruz. https://doi.org/10.1590/s0074-02762005000900016

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.